Current Affairs

Cipremi antiviral drug launched to treat against COVID19.


Daily Current Affairs

Cipremi antiviral drug launched to treat against COVID19.

Pharma major Cipla Limited has launched the generic medicine with the brand name “Cipremi” to treat the corona virus affected patients. (DCGI) Drug Controller General Of India has granted its approval to “cipremi” antiviral drug for restricted emergency use in the country as part of the accelerated approval process considering the urgent and unmet medical needs.

 “Remdesivir” generic antiviral drug has been received the only approval from USFDA to provide treatment for adult and paediatric patients hospitalized with suspected or laboratory-confirmed COVID -19 injection.

Highlights:

·         Hetero Pharma and Cipla both of the Indian pharmacy companies have received approval for its generic version of medicine called Remdesivir and started production and marketing in India

·         Cipla introduced the drug with the brand name CIPREMI in India and got approval from DCGI for restricted emergency use. Cipla has yet not disclosed its prices yet.

·         Cipla managing director and global CEO Vohra said, “ Cipla appreciates the strong partnership with Gilead to bring remdesivir to patients in India. We have been deeply invested in exploring all possible avenues to save millions of lives impacted by Covid-19 pandemic, and this the launch is a significant milestone in that direction.

·         Hetero Group of Companies chairman Partha Saradhi Reddy said: “In the light of increasing Covid-19 cases in India, the approval of ‘COVIFOR’ (Remdesivir) can prove to be a game-changer given its positive clinical outcomes.

Daily Current Affairs

Also Read Current Affairs in Tamil, Current Affairs in English, Download Current pdf in Tamil, Download Current Affairs in English, Upcoming Jobs            

Cipremi antiviral drug launched to treat against COVID19.